Return to content in this issue

Evaluation of fractional exhaled nitric oxide during SARS-CoV-2 infection

Betancor D¹, Valverde-Mongue M¹, Gomez-Lopez A¹, Barroso B¹, Ruete L², Olaguibel JM ^3,4, Sastre J<sup>1,4

1</sup>Allergy Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
²Eversens, Pamplona, Navarra, Spain
³Allergy Department, Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain
⁴CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain

J Investig Allergol Clin Immunol 2022; Vol. 32(4)
doi: 10.18176/jiaci.0762

• Abstract
• Supplemental Materials

Key words: SARS-CoV-2, COVID-19, Exhaled nitric oxide

	Title	Type	Size
	doi10.18176_jiaci.0762materialsupplfigure.pdf	pdf	181.54 Kb